文献速递流行病学与生物统计临床试验与 GCP基础与转化研究

HIV自检联合经济激励促进马拉维产前门诊男性伴侣检测与 linkage:适应性多臂多阶段整群随机试验

HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial.
PubMed 文献 · PLoS Med · 2019-01-02

该适应性多臂两阶段整群随机试验在马拉维布兰太尔三个初级卫生诊所的产前门诊开展,比较标准护理与五种干预(HIV自检、自检+固定激励3或10美元、自检+彩票、自检+电话提醒)对男性伴侣28天内检测并 linkage 至 care 或 prevention 的影响。结果显示自检+3美元、+10美元及电话提醒组的主要终点显著高于标准护理,而单独自检和彩票组无显著差异。

要点

  • HIV自检联合固定经济激励(3或10美元)可显著提高男性伴侣28天内检测并 linkage 至 care/prevention 的比例。
  • 单独提供HIV自检或彩票激励未显著增加主要终点,电话提醒有边缘显著效果。
  • 试验中确认HIV阳性的男性伴侣91.3%在28天内启动ART,未报告严重不良事件。

核心结论

  • 在马拉维产前门诊男性伴侣中,HIV自检联合有条件固定经济激励(3或10美元)可大幅提高28天内检测并 linkage 至 care 或 prevention 的比例。
  • 单独HIV自检或彩票激励未显著提高主要终点,电话提醒显示边缘显著效果。

研究设计与样本

  • 适应性多臂两阶段整群随机试验,以产前门诊日(单日就诊的妇女群)为随机单位,2016年8月8日至2017年6月30日在马拉维布兰太尔三个初级卫生诊所开展。
  • 共纳入3137名符合条件妇女中的2349名(74.9%),涉及71个产前门诊日,妇女平均年龄24.8岁(SD 5.4),男性伴侣平均年龄29.6岁(SD 7.5)。
  • 随机分为标准护理(给男性伴侣诊所邀请信)或五种干预之一:2个HIV自检试剂、自检+固定激励3美元、自检+固定激励10美元、自检+10%概率赢30美元彩票、自检+电话提醒。
  • 主要终点为报告男性伴侣在28天内检测HIV并 linkage 至 care 或 prevention 的比例,采用意向性分析,风险比调整男性伴侣检测史和招募诊所。

主要发现

  • 标准护理组报告17.4%(71/408)男性伴侣检测HIV,所有干预组报告检测比例均显著更高(87.0%-95.4%,p<0.001)。
  • 达到主要终点的比例:自检+3美元组几何均值40.9%(aRR 3.01,95%CI 1.63-5.57,p<0.001);自检+10美元组51.7%(aRR 3.72,95%CI 1.85-7.48,p<0.001);电话提醒组22.3%(aRR 1.58,95%CI 1.07-2.33,p=0.021);标准护理组13.0%。
  • 单独自检组几何均值17.5%(aRR 1.45,95%CI 0.99-2.13,p=0.130)和彩票组18.6%(aRR 1.43,95%CI 0.96-2.13,p=0.211)未显著增加主要终点,彩票组在中期分析时被终止。
  • 确认HIV阳性的46名男性伴侣中42名(91.3%)在28天内启动ART;222名检测阴性且未环切者中135名(60.8%)接受环切;未报告严重不良事件。
  • 自检+3美元和自检+10美元组每名带确认检测结果就诊的男性伴侣成本分别为23.73美元和28.08美元。

关键数值与推荐

  • 主要终点定义为报告男性伴侣在28天内检测HIV并 linkage 至 care 或 prevention(根据需要转介ART或环切)。
  • 与标准护理组几何均值13.0%相比,自检+3美元组aRR 3.01(95%CI 1.63-5.57,p<0.001),自检+10美元组aRR 3.72(95%CI 1.85-7.48,p<0.001),电话提醒组aRR 1.58(95%CI 1.07-2.33,p=0.021)。
  • 单独自检组aRR 1.45(95%CI 0.99-2.13,p=0.130)和彩票组aRR 1.43(95%CI 0.96-2.13,p=0.211)未达统计学显著。

临床怎么用

  • 在产前门诊场景中,向孕妇提供HIV自检试剂并联合有条件固定经济激励(3或10美元)可显著促进其男性伴侣检测并 linkage 至 care 或 prevention。
  • 单独提供自检试剂或彩票式激励效果不显著,电话提醒可作为辅助手段但效应较弱。

局限性

  • 每个干预臂随机分配的群数较少。
  • 男性伴侣检测结局为代理报告(由妇女报告)。
  • 无法评估 linkage 后的 care 保持情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conventional HIV testing services have been less comprehensive in reaching men than in reaching women globally, but HIV self-testing (HIVST) appears to be an acceptable alternative. Measurement of linkage to post-test services following HIVST remains the biggest challenge, yet is the biggest driver of cost-effectiveness. We investigated the impact of HIVST alone or with additional interventions on the uptake of testing and linkage to care or prevention among male partners of antenatal care clinic attendees in a novel adaptive trial. METHODS AND FINDINGS: An adaptive multi-arm, 2-stage cluster randomised trial was conducted between 8 August 2016 and 30 June 2017, with antenatal care clinic (ANC) days (i.e., clusters of women attending on a single day) as the unit of randomisation. Recruitment was from Ndirande, Bangwe, and Zingwangwa primary health clinics in urban Blantyre, Malawi. Women attending an ANC for the first time for their current pregnancy (regardless of trimester), 18 years and older, with a primary male partner not known to be on ART were enrolled in the trial after giving consent. Randomisation was to either the standard of care (SOC; with a clinic invitation letter to the male partner) or 1 of 5 intervention arms: the first arm provided women with 2 HIVST kits for their partners; the second and third arms provided 2 HIVST kits along with a conditional fixed financial incentive of $3 or $10; the fourth arm provided 2 HIVST kits and a 10% chance of receiving $30 in a lottery; and the fifth arm provided 2 HIVST kits and a phone call reminder for the women's partners. The primary outcome was the proportion of male partners who were reported to have tested for HIV and linked into care or prevention within 28 days, with referral for antiretroviral therapy (ART) or circumcision accordingly. Women were interviewed at 28 days about partner testing and adverse events. Cluster-level summaries compared each intervention versus SOC using eligible women as the denominator (intention-to-treat). Risk ratios were adjusted for male partner testing history and recruitment clinic. A total of 2,349/3,137 (74.9%) women participated (71 ANC days), with a mean age of 24.8 years (SD: 5.4). The majority (2,201/2,233; 98.6%) of women were married, 254/2,107 (12.3%) were unable to read and write, and 1,505/2,247 (67.0%) were not employed. The mean age for male partners was 29.6 years (SD: 7.5), only 88/2,200 (4.0%) were unemployed, and 966/2,210 (43.7%) had never tested for HIV before. Women in the SOC arm reported that 17.4% (71/408) of their partners tested for HIV, whereas a much higher proportion of partners were reported to have tested for HIV in all intervention arms (87.0%-95.4%, p < 0.001 in all 5 intervention arms). As compared with those who tested in the SOC arm (geometric mean 13.0%), higher proportions of partners met the primary endpoint in the HIVST + $3 (geometric mean 40.9%, adjusted risk ratio [aRR] 3.01 [95% CI 1.63-5.57], p < 0.001), HIVST + $10 (51.7%, aRR 3.72 [95% CI 1.85-7.48], p < 0.001), and phone reminder (22.3%, aRR 1.58 [95% CI 1.07-2.33], p = 0.021) arms. In contrast, there was no significant increase in partners meeting the primary endpoint in the HIVST alone (geometric mean 17.5%, aRR 1.45 [95% CI 0.99-2.13], p = 0.130) or lottery (18.6%, aRR 1.43 [95% CI 0.96-2.13], p = 0.211) arms. The lottery arm was dropped at interim analysis. Overall, 46 male partners were confirmed to be HIV positive, 42 (91.3%) of whom initiated ART within 28 days; 222 tested HIV negative and were not already circumcised, of whom 135 (60.8%) were circumcised as part of the trial. No serious adverse events were reported. Costs per male partner who attended the clinic with a confirmed HIV test result were $23.73 and $28.08 for the HIVST + $3 and HIVST + $10 arms, respectively. Notable limitations of the trial included the relatively small number of clusters randomised to each arm, proxy reporting of the male partner testing outcome, and being unable to evaluate retention in care. CONCLUSIONS: In this study, the odds of men's linkage to care or prevention increased substantially using conditional fixed financial incentives plus partner-delivered HIVST; combinations were potentially affordable. TRIAL REGISTRATION: ISRCTN 18421340.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Choko AT, Corbett EL, Stallard N, et al. HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial. PLoS Med. 2019. PMID: 30601823. doi:10.1371/journal.pmed.1002719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。